Cargando…
Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown etiology. At present, the mortality rate of the deadly disease is still very high, while the existing treatments only delay the progression of the disease and improve the quality of life of p...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965428/ https://www.ncbi.nlm.nih.gov/pubmed/36835236 http://dx.doi.org/10.3390/ijms24043818 |
_version_ | 1784896761028935680 |
---|---|
author | Yu, Rui Gao, Dandi Bao, Jiali Sun, Ronghao Cui, Mengqi Mao, Yunyun Li, Kai Hu, Enbo Zhai, Yanfang Liu, Yanhong Gao, Yuemei Xiao, Ting Zhou, Honggang Yang, Cheng Xu, Junjie |
author_facet | Yu, Rui Gao, Dandi Bao, Jiali Sun, Ronghao Cui, Mengqi Mao, Yunyun Li, Kai Hu, Enbo Zhai, Yanfang Liu, Yanhong Gao, Yuemei Xiao, Ting Zhou, Honggang Yang, Cheng Xu, Junjie |
author_sort | Yu, Rui |
collection | PubMed |
description | Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown etiology. At present, the mortality rate of the deadly disease is still very high, while the existing treatments only delay the progression of the disease and improve the quality of life of patients. Lung cancer (LC) is the most fatal disease in the world. In recent years, IPF has been considered to be an independent risk factor for the development of LC. The incidence of lung cancer is increased in the patients with IPF and the mortality is also significantly increased in the patients inflicted with the two diseases. In this study, we evaluated an animal model of pulmonary fibrosis complicated with LC by implanting LC cells orthotopically into the lungs of mice several days after bleomycin induction of the pulmonary fibrosis in the same mice. In vivo studies with the model showed that exogenous recombinant human thymosin beta 4 (exo-rhTβ4) alleviated the impairment of lung function and severity of damage of the alveolar structure by the pulmonary fibrosis and inhibited the proliferation of LC tumor growth. In addition, in vitro studies showed that exo-rhTβ4 inhibited the proliferation and migration of A549 and Mlg cells. Furthermore, our results also showed that rhTβ4 could effectively inhibit the JAK2-STAT3 signaling pathway and this might exert an anti-IPF-LC effect. The establishment of the IPF-LC animal model will be helpful for the development of drugs for the treatment of IPF-LC. Exogenous rhTβ4 can be potentially used for the treatment of IPF and LC. |
format | Online Article Text |
id | pubmed-9965428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99654282023-02-26 Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway Yu, Rui Gao, Dandi Bao, Jiali Sun, Ronghao Cui, Mengqi Mao, Yunyun Li, Kai Hu, Enbo Zhai, Yanfang Liu, Yanhong Gao, Yuemei Xiao, Ting Zhou, Honggang Yang, Cheng Xu, Junjie Int J Mol Sci Article Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown etiology. At present, the mortality rate of the deadly disease is still very high, while the existing treatments only delay the progression of the disease and improve the quality of life of patients. Lung cancer (LC) is the most fatal disease in the world. In recent years, IPF has been considered to be an independent risk factor for the development of LC. The incidence of lung cancer is increased in the patients with IPF and the mortality is also significantly increased in the patients inflicted with the two diseases. In this study, we evaluated an animal model of pulmonary fibrosis complicated with LC by implanting LC cells orthotopically into the lungs of mice several days after bleomycin induction of the pulmonary fibrosis in the same mice. In vivo studies with the model showed that exogenous recombinant human thymosin beta 4 (exo-rhTβ4) alleviated the impairment of lung function and severity of damage of the alveolar structure by the pulmonary fibrosis and inhibited the proliferation of LC tumor growth. In addition, in vitro studies showed that exo-rhTβ4 inhibited the proliferation and migration of A549 and Mlg cells. Furthermore, our results also showed that rhTβ4 could effectively inhibit the JAK2-STAT3 signaling pathway and this might exert an anti-IPF-LC effect. The establishment of the IPF-LC animal model will be helpful for the development of drugs for the treatment of IPF-LC. Exogenous rhTβ4 can be potentially used for the treatment of IPF and LC. MDPI 2023-02-14 /pmc/articles/PMC9965428/ /pubmed/36835236 http://dx.doi.org/10.3390/ijms24043818 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Rui Gao, Dandi Bao, Jiali Sun, Ronghao Cui, Mengqi Mao, Yunyun Li, Kai Hu, Enbo Zhai, Yanfang Liu, Yanhong Gao, Yuemei Xiao, Ting Zhou, Honggang Yang, Cheng Xu, Junjie Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title | Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title_full | Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title_fullStr | Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title_full_unstemmed | Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title_short | Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway |
title_sort | exogenous thymosin beta 4 suppresses ipf-lung cancer in mice: possibly associated with its inhibitory effect on the jak2/stat3 signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965428/ https://www.ncbi.nlm.nih.gov/pubmed/36835236 http://dx.doi.org/10.3390/ijms24043818 |
work_keys_str_mv | AT yurui exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT gaodandi exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT baojiali exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT sunronghao exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT cuimengqi exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT maoyunyun exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT likai exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT huenbo exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT zhaiyanfang exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT liuyanhong exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT gaoyuemei exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT xiaoting exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT zhouhonggang exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT yangcheng exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway AT xujunjie exogenousthymosinbeta4suppressesipflungcancerinmicepossiblyassociatedwithitsinhibitoryeffectonthejak2stat3signalingpathway |